Editor-in-Chief: Alaa Abd-Elsayed, MD, PhD
PDF
BACKGROUND: Infection with COVID-19 has evolved from a novel health crisis into an entity with a myriad of increasingly recognized sequelae. Among these, peripheral neuropathy is often an underrecognized and underdiagnosed complication. Neuropathic pain can be challenging to treat with many cases being refractory to conservative management, often requiring advanced techniques. Neuromodulation has become an important tool for the treatment of the refractory cases.
CASE REPORT: We present a case of a 43-year-old woman with refractory right tibial mononeuropathy secondary to COVID-19 infection who was treated successfully using peripheral nerve stimulation.
CONCLUSIONS: The use of peripheral neuromodulation represents a pivotal strategy for the management of difficult cases. Our case highlights the first use of neuromodulation to treat neuropathic pain secondary to COVID-19 infection. We hope that this case sparks further research on the topic, which could lead to better clarification of this condition and potential expansion of treatment strategies.
KEY WORDS: Neuromodulation, peripheral nerve stimulator, long COVID, tibial neuropathy, neuropathic pain
